US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 20.050
  • -0.090-0.45%
Trading Dec 13 12:01 ET
1.45BMarket Cap-167.08P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
67.37%112.21M
51.99%108.63M
65.18%79.86M
22.74%270.26M
34.76%83.4M
-32.37%67.05M
164.99%71.47M
50.19%48.35M
471.24%220.18M
230.14%61.88M
Operating revenue
67.37%112.21M
51.99%108.63M
65.18%79.86M
22.74%270.26M
34.76%83.4M
-32.37%67.05M
164.99%71.47M
50.19%48.35M
471.24%220.18M
230.14%61.88M
Cost of revenue
87.19%49.42M
95.23%42.34M
104.80%31.38M
45.91%33.41M
-204.92%-30M
128.37%26.4M
149.22%21.69M
22.86%15.32M
151.59%22.9M
-354.43%-9.84M
Gross profit
54.50%62.8M
33.15%66.3M
46.80%48.47M
20.06%236.85M
58.10%113.4M
-53.59%40.65M
172.50%49.79M
67.48%33.02M
570.03%197.29M
382.07%71.72M
Operating expense
40.49%72.46M
25.44%66.41M
47.04%65.02M
39.75%262.05M
72.54%113.32M
25.30%51.57M
40.66%52.94M
2.75%44.22M
0.77%187.51M
28.75%65.68M
Selling and administrative expenses
34.61%46.4M
45.31%42.4M
33.18%38.68M
32.13%129.43M
35.00%36.74M
39.68%34.47M
22.37%29.18M
30.73%29.05M
13.97%97.95M
19.67%27.22M
Research and development costs
52.33%26.06M
1.05%24.02M
73.57%26.33M
16.20%76.1M
39.35%20.05M
3.77%17.11M
72.25%23.77M
-27.12%15.17M
-34.05%65.49M
-47.54%14.39M
Other operating expenses
----
----
----
134.82%56.52M
----
----
----
----
2,782.75%24.07M
----
Operating profit
11.61%-9.66M
96.29%-117K
-47.75%-16.54M
-357.81%-25.2M
-98.66%81K
-123.54%-10.93M
83.72%-3.15M
51.99%-11.2M
106.24%9.77M
116.74%6.05M
Net non-operating interest income expense
Other net income (expense)
1.19%2.46M
26.42%2.42M
23.69%2.27M
581.88%8.54M
198.36%2.37M
654.04%2.43M
1,759.22%1.92M
5,288.24%1.83M
1,191.75%1.25M
794K
Other non- operating income (expenses)
1.19%2.46M
26.42%2.42M
23.69%2.27M
581.88%8.54M
198.36%2.37M
654.04%2.43M
1,759.22%1.92M
5,288.24%1.83M
1,191.75%1.25M
--794K
Income before tax
15.27%-7.2M
285.96%2.3M
-52.46%-14.28M
-251.02%-16.65M
-64.19%2.45M
-118.19%-8.5M
93.57%-1.24M
59.79%-9.36M
107.04%11.03M
118.97%6.84M
Income tax
2.54%5.49M
138.32%6.21M
17.96%3.43M
82.17%-30.74M
-1,057.44%-22.79M
103.02%5.36M
-2,364.11%-16.21M
50.96%2.91M
-12,543.10%-172.34M
753.05%2.38M
Net income
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
Net income continuous Operations
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
Minority interest income
Net income attributable to the parent company
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
Basic earnings per share
10.00%-0.18
-128.57%-0.06
-38.89%-0.25
-92.42%0.2
500.00%0.36
-106.19%-0.2
172.41%0.21
50.00%-0.18
214.78%2.64
111.32%0.06
Diluted earnings per share
10.00%-0.18
-128.57%-0.06
-38.89%-0.25
-92.31%0.2
483.33%0.35
-106.29%-0.2
172.41%0.21
50.00%-0.18
213.04%2.6
111.32%0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 67.37%112.21M51.99%108.63M65.18%79.86M22.74%270.26M34.76%83.4M-32.37%67.05M164.99%71.47M50.19%48.35M471.24%220.18M230.14%61.88M
Operating revenue 67.37%112.21M51.99%108.63M65.18%79.86M22.74%270.26M34.76%83.4M-32.37%67.05M164.99%71.47M50.19%48.35M471.24%220.18M230.14%61.88M
Cost of revenue 87.19%49.42M95.23%42.34M104.80%31.38M45.91%33.41M-204.92%-30M128.37%26.4M149.22%21.69M22.86%15.32M151.59%22.9M-354.43%-9.84M
Gross profit 54.50%62.8M33.15%66.3M46.80%48.47M20.06%236.85M58.10%113.4M-53.59%40.65M172.50%49.79M67.48%33.02M570.03%197.29M382.07%71.72M
Operating expense 40.49%72.46M25.44%66.41M47.04%65.02M39.75%262.05M72.54%113.32M25.30%51.57M40.66%52.94M2.75%44.22M0.77%187.51M28.75%65.68M
Selling and administrative expenses 34.61%46.4M45.31%42.4M33.18%38.68M32.13%129.43M35.00%36.74M39.68%34.47M22.37%29.18M30.73%29.05M13.97%97.95M19.67%27.22M
Research and development costs 52.33%26.06M1.05%24.02M73.57%26.33M16.20%76.1M39.35%20.05M3.77%17.11M72.25%23.77M-27.12%15.17M-34.05%65.49M-47.54%14.39M
Other operating expenses ------------134.82%56.52M----------------2,782.75%24.07M----
Operating profit 11.61%-9.66M96.29%-117K-47.75%-16.54M-357.81%-25.2M-98.66%81K-123.54%-10.93M83.72%-3.15M51.99%-11.2M106.24%9.77M116.74%6.05M
Net non-operating interest income expense
Other net income (expense) 1.19%2.46M26.42%2.42M23.69%2.27M581.88%8.54M198.36%2.37M654.04%2.43M1,759.22%1.92M5,288.24%1.83M1,191.75%1.25M794K
Other non- operating income (expenses) 1.19%2.46M26.42%2.42M23.69%2.27M581.88%8.54M198.36%2.37M654.04%2.43M1,759.22%1.92M5,288.24%1.83M1,191.75%1.25M--794K
Income before tax 15.27%-7.2M285.96%2.3M-52.46%-14.28M-251.02%-16.65M-64.19%2.45M-118.19%-8.5M93.57%-1.24M59.79%-9.36M107.04%11.03M118.97%6.84M
Income tax 2.54%5.49M138.32%6.21M17.96%3.43M82.17%-30.74M-1,057.44%-22.79M103.02%5.36M-2,364.11%-16.21M50.96%2.91M-12,543.10%-172.34M753.05%2.38M
Net income 8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M
Net income continuous Operations 8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M
Minority interest income
Net income attributable to the parent company 8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M
Basic earnings per share 10.00%-0.18-128.57%-0.06-38.89%-0.25-92.42%0.2500.00%0.36-106.19%-0.2172.41%0.2150.00%-0.18214.78%2.64111.32%0.06
Diluted earnings per share 10.00%-0.18-128.57%-0.06-38.89%-0.25-92.31%0.2483.33%0.35-106.29%-0.2172.41%0.2150.00%-0.18213.04%2.6111.32%0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data